Showing results (141-150 of 166) with videos related to

Sort By:
Pageof 17
European Heart Journal. Cardiovascular Pharmacotherapy|April 6, 2021
Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trialJoão Pedro Ferreira, Timothy Collier, Andrew L Clark, et al.
Lancet (London, England)|August 27, 2019
Identifying optimal doses of heart failure medications in men compared with women: a prospective, observational, cohort studyBernadet T Santema, Wouter Ouwerkerk, Jasper Tromp, et al.
Heart (British Cardiac Society)|May 10, 2024
Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trialYu-Ling Yu, Justyna Siwy, De-Wei An, et al.
European Journal of Heart Failure|April 1, 2010
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care MedicineMihai Gheorghiade, Ferenc Follath, Piotr Ponikowski, et al.
European Journal of Heart Failure|February 23, 2021
Haemodynamic effects of the nitroxyl donor cimlanod (BMS-986231) in chronic heart failure: a randomized trialNinian N Lang, Faheem A Ahmad, John G Cleland, et al.
European Journal of Heart Failure|November 7, 2019
Plasma proteomic approach in patients with heart failure: insights into pathogenesis of disease progression and potential novel treatment targetsThong H Cao, Donald J L Jones, Adriaan A Voors, et al.
European Journal of Heart Failure|December 19, 2017
Proteomic diversity of high-density lipoprotein explains its association with clinical outcome in patients with heart failureJohanna Elisabeth Emmens, Donald J L Jones, Thong H Cao, et al.
Circulation. Heart Failure|May 16, 2023
Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart StudyNicolas Girerd, Daniel Levy, Kevin Duarte, et al.
Clinical Proteomics|November 10, 2018
Using matrix assisted laser desorption ionisation mass spectrometry (MALDI-MS) profiling in order to predict clinical outcomes of patients with heart failureThong Huy Cao, Donald J L Jones, Paulene A Quinn, et al.
Ebiomedicine|July 30, 2026
Urinary proteomic signature of exercise intolerance in patients at risk of heart failure: evidence from the HOMAGE trialChu-Hao Liu, Dries S Martens, De-Wei An, et al.
Pageof 17